SCHEMBL23263197

SCHEMBL23263197

Cc1ncc(F)cc1-c1cccc(=O)c(OC(=O)OC(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.36
▸ RAF1 P04049 7/20 0.34
▸ BRAF P15056 4/20 0.33
▸ BRD4 O60885 2/20 0.33
▸ CTSA P10619 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ ELANE P08246 1/20 0.32
▸ PIK3C3 Q8NEB9 2/20 0.31
▸ RPS6KB1 P23443 1/20 0.31
▸ CSNK1D P48730 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ NTRK2 Q16620 1/20 0.31
▸ AURKB Q96GD4 1/20 0.31
▸ GCK P35557 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27018494 0.86 ABL1 (0.38) ABL1BRD4CTSAELANEPIK3C3
SCHEMBL23263206 0.84 ABL1 (0.37) ABL1BRD4FYNPIK3C3
SCHEMBL23263840 0.84 BRD4 (0.33) BRD4ELANEMTNR1AMTNR1B
SCHEMBL23263859 0.84 MKNK1 (0.40) ABL1BRD4ELANE
SCHEMBL23263920 0.83 HPGDS (0.40) FYNAURKBGABRA1GABRG2GABRB3
SCHEMBL23263130 0.82 NPSR1 (0.32) BRD4ELANEPIK3C3MTNR1AMTNR1B
SCHEMBL23263129 0.82 BACE1 (0.39) ABL1BRAFFYNRPS6KB1CSNK1D
SCHEMBL27018362 0.80 ELANE (0.35) BRD4FYNELANEGABRA1GABRG2
SCHEMBL23263181 0.80 GSK3B (0.35) BRD4ELANERPS6KB1CSNK1DGSK3A
SCHEMBL23263930 0.79 PTGES2 (0.39) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 — — US disclosed
WO-2021076945-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS TXNRD2, TXNRD1, SDHB ABL1 1266/4885RAF1 3486/4885BRAF 3865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback